Chemistry Nobel Honors the Mirror-Molecule Science Behind Modern Drug Making

Henri B. Kagan waited a long time. The Royal Swedish Academy of Sciences awarded him the 2026 Nobel Prize in Chemistry on October 7, at age 95, for work he published in 1986. In 2001 the chemistry prize honored asymmetric catalysis, the field he helped pioneer, and his name was not on it. According to Chemistry World, France's science minister at the time wrote to the Nobel committee to complain.

Kagan shares the prize with Kenso Soai, 76, of the Tokyo University of Science. The Academy cited them "for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis." Soai was shopping at a neighborhood supermarket when he learned he had won, the Associated Press reported, and he called it one of the most exciting days of his life.

Left Hands, Right Hands

Some molecules exist as two mirror images, like left and right hands. Chemists call them chiral, from the Greek word for hand. The two forms can behave differently. One version of the chemical carvone smells like mint; the other smells like caraway. In drug making the difference matters: the Academy notes that reactions forming both mirror images always gave equal amounts, while pharmaceutical work needs a single form.

The 2001 Nobel recognized catalysts that steer a reaction toward one mirror image. Those catalysts had to be made in a single-handed form themselves.

An Impure Starting Point, A Pure Product

Kagan's 1986 discovery changed the math. He found a new way of manipulating reactions that produced a greater excess of one mirror image than chemists had thought possible, a result called a non-linear effect. Scientific American reports he showed that specific catalysts can produce more of one handedness than the other.

Soai pushed the idea further. In 1995 he published the first reaction with the potential to be homochiral, meaning it could yield one mirror image only. In 2003 he presented a reaction where the product acts as its own catalyst (autocatalysis), the Soai reaction, that formed only one of the two mirror images. Somfai said the reaction can create one mirror image from nothing. The Academy says no one had achieved this feat apart from life itself.

Inside the Medicine Cabinet

The Academy says the discoveries have been decisive for chemists designing the reactions that manufacture pharmaceuticals. Rigoberto Hernandez, president of the American Chemical Society, told the Associated Press: "The medicines we have today would not be possible without this chemistry." Nobel committee member Peter Somfai said it is difficult to say that one drug or another was developed using the work, and that he would say all of them, because chemists use it as a tool and as an understanding of how catalysts function.

A Clue to How Life Picked a Side

The work also bears on a puzzle more than a century old. Life is one-handed: DNA twists to the right, and proteins build from mostly left-handed amino acids. Committee chair Heiner Linke said the laureates have provided a solution to that chemical mystery. Somfai said the discovery could be key to understanding how life first arose on Earth. Soai himself said the question of how amino acid handedness first emerged remains unresolved and that his work is not the final answer.

What Is Known and What Is Still Open

The established part is a pair of results. Kagan showed in 1986 that reactions can yield a greater excess of one mirror image than previously thought possible, and Soai showed in 2003 that autocatalysis can produce a single mirror image. Somfai says chemists use the work as a tool, and the Academy calls the discoveries decisive for pharmaceutical reaction design.

The open part is the beginning of life's handedness. The Soai reaction shows how a small bias can grow; it does not show what supplied the first bias on early Earth. Soai says that question is still unresolved. The prize arrived after the science had held up for decades, and the question it points to stays open.